Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk

References

• Agency for Toxic Substances and Disease Registry (ATSDR) (2003). ToxFAQs™ for pyrethrins and pyrethroids—September 2003. U.S. Department of Health and Human Services, Atlanta, GA.
   Google Scholar
• Baker, T.K., Bachowski, S., Stevenson, D.E., Walborg, E.F., Jr., and Klaunig, J.E. (1995). Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. Prog. Clin. Biol. Res. 391: 71–80.
   PubMedGoogle Scholar
• Bentley P., Calder I., Elcombe C., Grasso P., Stringer D., and Wiegand H.-J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31: 857–907.
   PubMed Web of Science ®Google Scholar
• Bhat, B.K. (1995). Breeding methodologies applicable to pyrethrum. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 67–94. Oxford University Press, New York.
   Google Scholar
• Boobis, A.R., Cohen, S.M., Dellarco, V., McGregor, D., Meek, B.E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36: 781–792.
   PubMed Web of Science ®Google Scholar
• Casida J.E., and Quistad, G.B. (1995). Metabolism and synergism of pyrethrins. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 258–276. Oxford University Press, New York.
   Google Scholar
• Chang, T.K.H., Yu, L., Maurel, P., and Waxman, D.J. (1997). Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res. 57: 1946–1954.
   PubMed Web of Science ®Google Scholar
• Chipman, J.K., Mally, A., and Edwards, G.O. (2003). Disruption of gap junctions in toxicity and carcinogenicity. Toxicol. Sci. 71: 146–153.
   PubMed Web of Science ®Google Scholar
• Cohen, S.M., Klaunig, J., Meek, M.E., Hill, R.N., Pastoor, T., Lehman-McKeeman, L., Bucher, J., Longfellow, D.G., Seed, J., Dellarco, V., Fenner-Crisp, P., and Patton, D. (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicol. Sci. 78: 181–186.
   PubMed Web of Science ®Google Scholar
• Cohen, S.M., Meek, M.E., Klaunig, J.E., Patton, D.E., and Fenner-Crisp, P.A. (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit. Rev. Toxicol. 33: 581–589.
   PubMed Web of Science ®Google Scholar
• Crampton, R.F., Gray, T.J.B., Grasso, P., and Parke, D.V. (1977). Long-term studies on chemically induced liver enlargement in the rat. I. Sustained induction of microsomal enzymes with absence of liver damage on feeding phenobarbitone or butylated hydroxytoluene. Toxicology 7: 289–306.
   Web of Science ®Google Scholar
• Cunningham, M.L. (1996). Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat. Res. 365: 59–69.
   PubMed Web of Science ®Google Scholar
• Dellarco, V.L., McGregor, D., Berry, C., Cohen, S.M., and Boobis, A.R. (2006). Thiazopyr and thyroid disruption: Case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a Cancer Mode of Action. Crit. Rev. Toxicol. 36: 792–801.
   Web of Science ®Google Scholar
• Doull, J., Cattley, R., Elcombe, C., Lake, B.G., Swenberg, J., Wilkinson, C., Williams, G., and van Gemert, M., 1999. A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA Risk Assessment Guidelines. Regul. Toxicol. Pharmacol. 29: 327–357.
   PubMed Web of Science ®Google Scholar
• Finch, J.M., Osimitz, T.G., Gabriel, K.L., Martin, T., Henderson, W.J., Capen, C.C., Butler, W.H., and Lake, B.G. (2006). A mode of action for induction of thyroid gland tumors by pyrethrins in the rat. Toxicol. Appl. Pharmacol. 214: 253–262.
   PubMed Web of Science ®Google Scholar
• Gerbal-Chaloin, S., Pascussi, J.-M., Pichard-Garcia, L., Daujat, M., Waechter, F., Fabre, J.-M., Carrère, N., and Maurel, P. 2001. Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab. Dispos. 29: 242–251.
   PubMed Web of Science ®Google Scholar
• Gerberg, E.J. (1995). Pyrethrum for control of pests of medical and veterinary importance. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 302–310. Oxford University Press, New York.
   Google Scholar
• Gold, L.S., Manley, N.B., Slone, T.H., and Ward, J.M. (2001). Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol. Pathol. 29: 639–652.
   PubMed Web of Science ®Google Scholar
• Grasso, P., and Hinton, R.H. (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutat. Res. 248: 271–290.
   PubMed Web of Science ®Google Scholar
• Hasmall, S.C., and Roberts, R.A. (1999). The perturbation of apoptosis and mitosis by drugs and xenobiotics. Pharmacol Ther. 82: 63–70.
   PubMed Web of Science ®Google Scholar
• Holsapple, M.P., Pitot, H.C., Cohen, S.H., Boobis, A.R., Klaunig, J.E., Pastoor, T., Dellarco, V.L., and Dragan, Y.P. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 89: 51–56.
   PubMed Web of Science ®Google Scholar
• Honkakoski, P., and Negishi, M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347:321–337.
   PubMed Web of Science ®Google Scholar
• Huang, W., Zhang, J., Wahington, M., Liu, J., Parant, J.M., Lozano, G., and Moore, D.D., 2005. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 19: 1646–1653.
   PubMed Web of Science ®Google Scholar
• Huff, J., Cirvello, J., Haseman, J., and Bucher, J. (1991). Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect. 93: 247–270.
   PubMed Web of Science ®Google Scholar
• Hurley, P.M., Hill, R.N., and Whiting, R.J. (1998). Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ. Health Perspect. 106: 437–445.
   PubMed Web of Science ®Google Scholar
• IARC (2001). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 79. Some Thyrotropic Agents. IARC Press, Lyon.
   Google Scholar
• Kennedy, M.K., and Hamilton, R.L. (1995). Pyrethrum for control of insects in the home. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 311–327. Oxford University Press, New York.
   Google Scholar
• Klaunig, J.E. (2006). Examination of mode of action of pyrethrins tumorigenesis in mammals. Unpublished report submitted to U.S. EPA (MRID No. 46792704).
   Google Scholar
• Klaunig, J.E., Ruch, R.J., and Weghorst, C.M. (1990). Comparative effects of phenobarbital, DDT, and lindane on mouse hepatocyte gap junctional intercellular communication. Toxicol. Appl. Pharmacol. 102: 553–563.
   PubMed Web of Science ®Google Scholar
• Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., DeLuca, J.G., Lai, D.Y., McKee, R.H., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. (2003). PPAR-alpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33: 655–780.
   PubMed Web of Science ®Google Scholar
• Kolaja, K.L., Stevenson, D.E., Johnson, J.T., Walborg, E.F., Jr., and Klaunig, J.E. (1996). Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam. Appl. Toxicol. 29:219–228.
   PubMedGoogle Scholar
• Lake, B.G. (1995). Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol. 35: 483–507.
   PubMed Web of Science ®Google Scholar
• Lake, B.G., Longland, R.C., Harris, R.A., Severn, B.J., and Gangolli, S.D. (1978). The effect of prolonged sodium phenobarbitone treatment on hepatic xenobiotic metabolism and the urinary excretion of metabolites of the D-glucuronic acid pathway in the rat. Biochem. Pharmacol. 27: 2357–2361.
   PubMed Web of Science ®Google Scholar
• Madan, A., Graham, R.A., Carroll, K.M., Mudra, D.R., Burton, L.A., Krueger, L.A., Downey, A.D., Czerwinski, M., Forster, J., Ribadeneira, M.D., Gan, L.-S., LeCluyse, E.L., Zech, K., Robertson, P., Jr., Koch, P., Antonian, L., Wagner, G., Yu, L., and Parkinson, A. (2003). Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab. Dispos. 31: 421–431.
   PubMed Web of Science ®Google Scholar
• Meek, M.E., Bucher, J.R., Cohen, S.M., Dellarco, V., Hill R.N., Lehman-McKeeman, L.D., Longfellow, D.G., Pastoor, T., Seed, J, and Patton, D.E. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33: 591–653.
   PubMed Web of Science ®Google Scholar
• Moore, J.T., Moore, L.B., Maglich, J.M., and Kliewer, S.A. (2003). Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta 1619: 235–238.
   PubMed Web of Science ®Google Scholar
• Neveu, M.J., Babcock, K.L., Hertzberg, E.L., Paul, D.L., Nicholson, B.J., and Pitot, H.C. (1994). Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res. 54: 3145–3152.
   PubMed Web of Science ®Google Scholar
• Nims, R.W., and Lubet, R.A. (1996). The CYP2B subfamily, In: Cytochromes P450: Metabolic and Toxicological Aspects, C. Ioannides ed., pp. 135–160. CRC Press, Boca Raton, FL.
   Google Scholar
• Olsen, J.H., Boice, J.D., Jr, Jensen, J.P.A., and Fraumeni, J.F., Jr. (1989). Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81: 803–808.
   PubMed Web of Science ®Google Scholar
• Olsen, J.H., Schulgen, G., Boice, J.D., Jr, Whysner, J., Travis, L.B., Williams, G.M., Johnson, F.B., and McGee, J.O’D. (1995). Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res. 55: 294–297.
   PubMed Web of Science ®Google Scholar
• Orton, T.C., Doughty, S.E., Kalinowski, A.E., Lord, P.G., and Wadsworth, P.F. (1996). Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis 17: 973–981.
   PubMed Web of Science ®Google Scholar
• Parkinson, A. (2001). Biotransformation of xenobiotics, In: Casarett and Doull’s Toxicology: The Basic Science of Poisons, 6th edition, C.D. Klaassen, ed., pp. 133−224. McGraw Hill, New York.
   Google Scholar
• Parzefall, W. Erber, E., Sedivy, R., and Schulte-Hermann, R. (1991). Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res. 51: 1143–1147.
   PubMed Web of Science ®Google Scholar
• Pelkonen, O., Mäenpää, J., Taavitsainen, P., Rautio, A., and Raunio, H. (1998). Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203–1253.
   PubMed Web of Science ®Google Scholar
• Phillips, J.C., Price, R.J., Cunninghame, M.E., Osimitz, T.G., Cockburn, A., Gabriel, K.L., Preiss, F., Butler, W.H., and Lake, B.G. (1997). Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats. Fundam. Appl. Toxicol. 38: 64–74.
   PubMedGoogle Scholar
• Pirttiaho H.I., Sotaniemi E.A., Ahokas, J.T., and Pitkänen U. (1978). Liver size and indices of drug metabolism in epileptics. Brit.. J. Clin. Pharmacol. 6: 273–278.
   PubMed Web of Science ®Google Scholar
• Pirttiaho H.I., Sotaniemi E.A., Pelkonen, R.O., and Pitkänen U. (1982). Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur. J. Clin. Pharmacol. 22: 441–445.
   PubMed Web of Science ®Google Scholar
• Price, R.J., Giddings, A.M., Scott, M.P., Walters, D.G., Capen, C.C., Osimitz, T.G., and Lake, B.G. (2008). Effect of pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes. Toxicology 243: 84–95.
   PubMed Web of Science ®Google Scholar
• Price, R.J., Walters, D.G., Finch, J.M., Gabriel, K.L., Capen, C.C., Osimitz, T.G., and Lake, B.G. (2007). A mode of action for induction of liver tumors by pyrethrins in the rat. Toxicol. Appl. Pharmacol. 218: 186–195.
   PubMed Web of Science ®Google Scholar
• Schoenig, G.P., 1995. Mammalian toxicology of pyrethrum extract. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 249–257. Oxford University Press, New York.
   Google Scholar
• Silcox, C.A., and Roth, E.S. (1995). Pyrethrum for control of pests of agricultural and stored products. In: Pyrethrum Flowers Production, Chemistry, Toxicology, and Uses, J.E Casida and G.B. Quistad, eds., pp. 287–301. Oxford University Press, New York.
   Google Scholar
• Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., Mangelsdorf, I., Meek, E., Rice, J.M., and Younes, M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34:146–152.
   PubMed Web of Science ®Google Scholar
• Tien, E.S., and Negishi, M. (2006). Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 36: 1152–1163.
   PubMed Web of Science ®Google Scholar
• U.S., Environmental Protection Agency (EPA) (2005). Pyrethrins: Revised Human Health Risk Assessment for the Reregistration Eligibility Decision. Case No. 2580. PC Code: 069001; DP Barcode: D321641. September 14.
   Google Scholar
• U.S., Environmental Protection Agency (EPA) (2008). Evaluation of the Carcinogenic Potential of pyrethrins (Fourth Review), PC code 069001. Cancer Assessment Review Committee, Health Effects Division, Office of Pesticide Programs, Washington, DC. February 14.
   Google Scholar
• Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D.D. (2000). The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407: 920–923.
   PubMed Web of Science ®Google Scholar
• Whysner, J., Ross, P.M., and Williams, G.M. (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71: 153–191.
   PubMed Web of Science ®Google Scholar
• Yamamoto, Y., Moore, R., Goldsworthy, T.L., Negishi, M., and Maronpot, R.R. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64: 7197–7200.
   PubMed Web of Science ®Google Scholar
• Yoshinari, K., Tien, E., Negishi, M., and Honkakoski, P., (2008). Receptor-mediated regulation of cytochromes P450. In: Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics, C. Ioannides ed., pp. 417–448. RSC Publishing, Cambridge.
   Google Scholar